Maternal exposure to bisphenol A may increase the risks of Parkinson's disease through down-regulation of fetal IGF-1 expression

Medical Hypotheses

Volumn 82, Issue 3, 2014, Pages 245-249

  Huang, Boxian ^a,b   Jiang, Chunyan ^b   Luo, Jian ^b   Cui, Yugui ^b   Qin, Lianju ^b   Liu, Jiayin ^a,b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; BENZHYDRYL COMPOUNDS; DOWN-REGULATION; FEMALE; FETUS; INSULIN-LIKE GROWTH FACTOR I; MATERNAL EXPOSURE; PARKINSON DISEASE; PHENOLS; PREGNANCY; RISK FACTORS;

EID: 84893922416     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2013.10.023     Document Type: Article

References (61)

1. Lang A.E., Lozano A.M. Parkinson's disease. First of two parts. N Engl J Med 1998, 339:1044-1053.
2. Lang A.E., Lozano A.M. Parkinson's disease. Second of two parts. N Engl J Med 1998, 339:1130-1143.
3. Fahn S. Description of Parkinson's disease as a clinical syndrome. Ann NY Acad Sci 2003, 991:1-14.
4. Wang X.F., Li S., Chou A.P., Bronstein J.M. Inhibitory effects of pesticides on proteasome activity: implication in Parkinson's disease. Neurobiol Dis 2006, 23(1):198-205.
5. Langston J.W., Ballard P., Tetrud J.W., Irwin I. Chronicparkinsonism in humans due to a product of meperidine-analogsynthesis. Science 1983, 219(4587):979-980.
6. Singhal N.K., Srivastava G., Agrawal S., Jain S.K., Singh M.P. Melatonin as a neuroprotective agent in the rodent models of Parkinson's disease: is it all set to irrefutable clinical translation?. Mol Neurobiol 2012, 45(1):186-199.
7. Godeiro C., Aguiar P.M., Felício A.C., Barsottini O.G., Silva S.M., Borges V., et al. PINK1 polymorphism IVS1-7 A→G, exposure to environmental risk factors and anticipation of disease onset in Brazilian patients with early-onset Parkinson's disease. Neurosci Lett 2010, 469(1):155-158.
8. Vogel S.A. The politics of plastics: the making and unmaking of bisphenol a "safety". Am J Public Health 2009, 99(Suppl. 3):S559-S566.
9. Welshons W.V., Nagel S.C., vom Saal F.S. Large effects from small exposures: III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 2006, 147(Suppl. 6):S56-S69.
10. Mountfort K.A., Kelly J., Jickells S.M., Castle L. Investigations into the potential degradation of polycarbonate baby bottles during sterilization with consequent release of bisphenol A. Food Addit Contam 1997, 14(6-7):737-740.
11. Kang J.H., Kito K., Kondo F. Factors influencing the migration of bisphenol A from cans. J Food Prot 2003, 66(8):1444-1447.
12. Goodson A., Robin H., Summerfield W., Cooper I. Migration of bisphenol A from can coating-seffects of damage, storage conditions and heating. Food Addit Contam 2004, 21(10):1015-1026.
13. Calafat A.M., Kuklenyik Z., Reidy J.A., Caudill S.P., Ekong J., Needham L.L. Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect 2005, 113(4):391-395.
14. Olea N., Pulgar R., Perez P., et al. Estrogenicity of resin-based composites and sealants used in dentistry. Environ Health Perspect 1996, 104(3):298-305.
15. Vandenberg L.N., Maffini M.V., Wadia P.R., Sonnenschein C., Rubin B.S., Soto A.M. Exposure to environmentally relevant doses of the xenoestrogen bisphenol-A alters development of the fetal mouse mammary gland. Endocrinology 2007, 148(1):116-127.
16. Calafat A.M., Ye X., Wong L.Y., Reidy J.A., Needham L.L. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ Health Perspect 2008, 116(1):39-44.
17. CDC, Fourth national report on human exposure to environmental chemicals. Centers for Disease Control and Prevention; National Center for Environmental Health; Division of Laboratory Sciences, Atlanta, GA. 2009.
18. Yamada H., Furuta I., Kato E.H., Kataoka S., Usuki Y., Kobashi G., et al. Maternal serum and amniotic fluid bisphenol A concentrations in the early second trimester. Reprod Toxicol 2002, 16(6):735-739.
19. Geens T., Neels H., Covaci A. Distribution of bisphenol-A, triclosan and n-nonylphenol in human adipose tissue, liver and brain. Chemosphere 2012, 87(7):796-802.
20. Doerge D.R., Twaddle N.C., Vanlandingham M., Fisher J.W. Pharmacokinetics of bisphenol A in serum and adipose tissue following intravenous administration to adult female CD-1 mice. Toxicol Lett 2012, 211(2):114-119.
21. Markey C.M., Luque E.H., Munoz De Toro M., Sonnenschein C., Soto A.M. In utero exposure to bisphenol A alters the development and tissue organization of the mouse mammary gland. Biol Reprod 2001, 65(4):1215-1223.
22. Nikaido Y., Yoshizawa K., Danbara N., Tsujita-Kyutoku M., Yuri T., Uehara N., et al. Effects of maternal xenoestrogen exposure on development of the reproductive tract and mammary gland in female CD-1 mouse offspring. Reprod Toxicol 2004, 18(6):803-811.
23. Timms B.G., Howdeshell K.L., Barton L., Bradley S., Richter C.A., vom Saal F.S. Estrogenic chemicals in plastic and oral contraceptives disrupt development of the fetal mouse prostate and urethra. Proc Natl Acad Sci USA 2005, 102(19):7014-7019.
24. Munoz-de-Toro M., Markey C.M., Wadia P.R., Luque E.H., Rubin B.S., Sonnenschein C., et al. Perinatal exposure to bisphenol-A alters peripubertal mammary gland development in mice. Endocrinology 2005, 146(9):4138-4147.
25. Russo V.C., Gluckman P.D., Feldman E.L., Werther G.A. The insulin-like growth factor system and its pleiotropic functions in brain. Endocr Rev 2005, 26(7):916-943.
26. Nyberg F. Growth hormone in the brain: characteristics of specific brain targets for the hormone and their functional significance. Front Neuroendocrinol 2000, 21(4):330-348.
27. Scheepens A., Williams C.E., Breier B.H., Guan J., Gluckman P.D. A role for the somatotropic axis in neural development, injury and disease. J Pediatr Endocrinol 2000, 13(Suppl. 6):1483-1491.
28. Nishijima T., Piriz J., Duflot S., et al. Neuronal activity drives localized blood-brain-barrier transport of serum insulin-like growth factor-I into the CNS. Neuron 2010, 67(5):834-846.
29. Itoh K., Yaoi T., Fushiki S. Bisphenol A, an endocrine-disrupting chemical, and brain development. Neuropathology 2012, 32(4):447-457.
30. Kabil A., Silva E., Kortenkamp A. Estrogens and genomic instability in human breast cancer cells-involvement of Src/Raf/Erk signaling in micronucleus formation by estrogenic chemicals. Carcinogenesis 2008, 29(10):1862-1868.
31. Kelly Geraldine M., Buckley Deirdre A., Kiely Patrick A., Adams D.R., O'Connor R. Serine phosphorylation of the insulin-like growth factor I receptor C-terminal tail restrains kinase activity and cell growth. J Biol Chem 2012, 287(33):28180-28194.
32. Corvin Aiden.P., Molinos Ines., Little Graham., et al. Insulin-like growth factor 1 and its active peptide (1-3) IGF1 enhance the expression of synaptic markers in neuronal circuits through different cellular mechanisms. Neurosci Lett 2012, 520(1):51-56.
33. Yan H., Mitschelen M., Bixler G.V., et al. Circulating IGF1 regulates hippocampal IGF1 levels and brain gene expression during adolescence. J Endocrinol 2011, 211(1):27-37.
34. Bateman H.L., Patisaul H.B. Disrupted female reproductive physiology following neonatal exposure to phytoestrogens or estrogen specific ligands is associated with decreased GnRH activation and kisspeptin fiber density in the hypothalamus. Neurotoxicology 2008, 29(6):988-997.
35. Netchine I., Azzi S., Bouc Y.L., Savage M.O. IGF1 molecular anomalies demonstrate its critical role in fetal, postnatal growth and brain development. Best Pract Res Clin Endocrinol Metabo 2011, 25(1):181-190.
36. Poirier R., Fernandez A.M., Torres-Aleman I., Metzger F. Early brain amyloidosis in APP/PS1 mice with serum insulin-like growth factor-I deficiency. Neurosci Lett 2012, 509(2):101-104.
37. Yan Y.P., Sailor K.A., Vemuganti R., Dempsey R.J. Insulin-like growth factor-1 is an endogenous mediator of focal ischemia-induced neural progenitor proliferation. Eur J Neurosci 2006, 24(1):45-54.
38. Arsenijevic Y., Weiss S., Schneider B., Aebischer P. Insulin-like growth factor-I is necessary for neural stem cell proliferation and demonstrates distinct actions of epidermal growth factor and fibroblast growth factor-2. J Neurosci 2001, 21(18):7194-7202.
39. Nitta A., Zheng W., Quirion R. Insulin-like growth factor 1 prevents neuronal cell death induced by corticosterone through activation of the PI3K/Akt pathway. J Neurosci Res 2004, 76(1):98-103.
40. Zheng W., Quirion R. Comparative signaling pathways of insulin-like growth factor-1 and brain-derived neurotrophic factor in hippocampal neurons and the role of PI3 kinase pathway in cell survival. J Neurochem 2004, 89(4):844-852.
41. Johnson-Farley N.N., Travkina T., Cowen D.S. Cumulative activation of neuroprotective Akt pathway by brain-derived neurotrophic factor and insulin-like growth factor-1 in cultured hippocampal neurons. J Pharmacol Exp Ther 2006, 316(3):1062-1069.
42. Ebert Allison.D., Beres Amy.J., Barber Amelia.E., Svendsen Clive.N. Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease. Exp Neurol 2008, 209(1):213-223.
43. Chung Ji.Yun., Lee Su.Jin., Lee Sun.Hye., et al. Direct interaction of α-Synuclein and AKT regulates IGF-1 signaling: implication of Parkinson disease. Neurosignals 2011, 19(2):86-96.
44. Guan J., Krishnamurthi R., Waldvogel H.J., Faull R.L., Clark R., Gluckman P. N-terminal tripeptide of IGF-1 (GPE) prevents the loss of TH positive neurons after 6-OHDA induced nigral lesion in rats. Brain Res 2000, 859(2):286-292.
45. Krishnamurthi R., Stott S., Maingay M., et al. N-terminal tripeptide of IGF-1 improves functional deficits after 6-OHDA lesion in rats. Neuroreport 2004, 15(10):1601-1604.
46. Quesada A., Micevych P.E. Estrogen interacts with the IGF-1 system to protect nigrostriatal dopamine and maintain motoric behavior after 6-hydroxdopamine lesions. J Neurosci Res 2004, 75(1):107-116.
47. Picillo Marina., Erro Roberto., Santangelo Gabriella., et al. Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease. J Neurol 2013, 260(7):1724-1730.
48. Hwang KA, Kang NH, Yi BR, Hyun SH, Jeung EB, Choi KC. Anticancer effect of genistein on BG-1 ovarian cancer growth induced by 17 β-Estradiol or bisphenol A via the suppression of the crosstalk between estrogen receptor and insulin-like growth factor 1 receptor signaling pathways. Toxicol Appl Pharmacol 2013;S0041-008X(13).
49. Jenkins Sarah., Wang Jun., Eltoum Isam., Desmond R., Lamartiniere C.A. Chronic oral exposure to bisphenol A results in a nonmonotonic dose response in mammary carcinogenesis and metastasis in MMTV-erbB2 mice. Environ Health Perspect 2011, 119(11):1604-1609.
50. Aluru Neelakanteswar., Leatherland John F., Vijayan Mathilakath M. Bisphenol A in oocytes leads to growth suppression and altered stress performance in juvenile rainbow trout. PLoS One 2010, 5(5):e10741.
51. Yan H., Mitschelen M., Bixler G.V., et al. Circulating IGF1 regulates hippocampal IGF1 levels and brain gene expression during adolescence. J Endocrinol 2011, 211(1):27-37.
52. Nakamura K., Itoh K., Yaoi T., Fujiwara Y., Sugimoto T., Fushiki S. Murine neocortical histogenesis is perturbed by prenatal exposure to low doses of bisphenol A. J Neurosci Res 2006, 84(6):1197-1205.
53. Nakamura K., Itoh K., Yoshimoto K., Sugimoto T., Fushiki S. Prenatal and lactational exposure to low-doses of bisphenol A alters brain monoamine concentration in adult mice. Neurosci Lett 2010, 484(1):60-70.
54. Matsuda Shingo, Matsuzawa Daisuke, Ishii Daisuke, et al. Effects of perinatal exposure to low dose of bisphenol A on anxiety like behavior and dopamine metabolites in brain. Prog Neuro Psychopharmacol Biol Psychiatry 2012, 39(2):273-279.
55. Yang Yoon Jung, Hong Yun Chul, Oh Se Young Bisphenol A exposure is associated with oxidative stress and inflammation in postmenopausal women. Environ Res 2009, 109(6):797-801.
56. Bauer S.M., Roy A., Emo J., Chapman T.J., Georas S.N., Lawrence B.P. The Effects of maternal exposure to bisphenol A on allergic lung inflammation into adulthood. Toxicol Sci 2012, 130(1):82-93.
57. Kundakovic Marija, Gudsnuk Kathryn, Franks Becca, et al. Sex-specific epigenetic disruption and behavioral changes following low-dose in utero bisphenol A exposure. Proc Natl Acad Sci USA 2013, 110(24):9956-9961.
58. Jang Young Jung, Park Hee Ra, Kim Tae Hyung High dose bisphenol A impairs hippocampal neurogenesis in female mice across generations. Toxicology 2012, 296(1-3):73-82.
59. Bhattacharya B., Cai J., Luo Y., et al. Comparison of the gene expression profile of undifferentiated human embryonic stem cell lines and differentiating embryoid bodies. BMC Dev Biol 2005, 5:22.
60. Dvash T., Mayshar Y., Darr H., et al. Temporal gene expression during differentiation of human embryonic stem cells and embryoid bodies. Hum Reprod 2004, 19(12):2875-2883.
61. Cho Myung Soo, Lee Young-Eun, Kim Ji Young Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci USA 2008, 105(9):3392-3397.